Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology
Philadelphia, PA, July 1, 2015 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition of InferMed, a London-based clinical decision support (CDS) technology company.
InferMed's Arezzo technology supports clinicians in choosing the most appropriate treatment path for each patient. Arezzo matches appropriate evidence-based guidelines with patient information and dynamically evaluates best-practice options in the light of current patient and disease information. Arezzo helps physicians improve care outcomes while taking unnecessary costs out of the system.